Vystar Corporation Asset Turnover Ratio (VYST), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vystar Corporation  (VYST)
 

Vystar Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vystar's asset turnover ratio, the ratio that measures the ability of Vystar's assets to generate revenue, sequentially decreased to 0.1 in the first quarter (Mar 31 2026), which does not come as a surprise, as the Vystar continue to experience difficult business climate.

Within sector 153 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2881 to 2942.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VYST Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -20.34 % -18.23 % -17.94 % -19.78 % -14.75 %
Y / Y Revenue Change -51.43 % 41.19 % -61.61 % -69.49 % -66.34 %
Asset Turnover Ratio (TTM) 0.1 0.11 0.1 0.15 0.19
VYST's Total Ranking # 2942 # 2881 # 3081 # 1229 # 1228
Seq. Asset Change -3.19 % -6.46 % -4.34 % -8.04 % -0.62 %
Seq. Revenue Change -39.52 % -50.14 % 75.51 % -8.23 % 75.82 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 154
Healthcare Sector # 452
Overall Market # 2942

Asset Turnover Ratio Statistics
High Average Low
1.46 0.53 -0.15
(Jun 30 2021)   (Sep 30 2023)




VYST Company Profile • Back to VYST Efficiency Comparisons • Compare VYST Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Humacyte Inc   0.30 $ 34.376  Millions$ 114.307  Millions
Utah Medical Products Inc  0.30 $ 36.745  Millions$ 122.425  Millions
Opko Health Inc   0.30 $ 581.123  Millions$ 1,939.309  Millions
Ptc Therapeutics inc   0.30 $ 827.110  Millions$ 2,761.432  Millions
Fortress Biotech Inc   0.30 $ 66.161  Millions$ 220.931  Millions
Invivyd Inc   0.30 $ 55.866  Millions$ 186.730  Millions
Gossamer Bio Inc   0.30 $ 55.537  Millions$ 187.723  Millions
Reshape Lifesciences Inc  0.30 $ 2.421  Millions$ 8.185  Millions
Innovative Eyewear Inc   0.28 $ 2.981  Millions$ 10.683  Millions
Hyperfine Inc   0.27 $ 13.849  Millions$ 50.587  Millions
Orasure Technologies Inc  0.27 $ 112.581  Millions$ 412.618  Millions
Immunitybio inc   0.27 $ 140.977  Millions$ 517.400  Millions
Fulgent Genetics Inc   0.27 $ 319.019  Millions$ 1,196.074  Millions
Repligen Corp  0.26 $ 763.339  Millions$ 2,926.452  Millions
Zomedica Corp   0.26 $ 33.355  Millions$ 128.987  Millions
Adc Therapeutics Sa  0.26 $ 79.175  Millions$ 306.491  Millions
Neogen Corporation  0.26 $ 871.509  Millions$ 3,385.236  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.300  Millions$ 10,069.250  Millions
Teleflex Incorporated  0.25 $ 1,838.287  Millions$ 7,244.350  Millions
Innoviva Inc   0.25 $ 394.185  Millions$ 1,558.608  Millions
Maravai Lifesciences Holdings Inc   0.25 $ 203.841  Millions$ 807.488  Millions
Retractable Technologies Inc  0.25 $ 36.180  Millions$ 143.438  Millions
Biolife Solutions Inc   0.25 $ 99.673  Millions$ 396.528  Millions
Opus Genetics Inc   0.25 $ 11.983  Millions$ 47.954  Millions
Hcw Biologics Inc   0.25 $ 6.592  Millions$ 26.554  Millions
Keenova Therapeutics Plc  0.25 $ 1,413.000  Millions$ 5,720.150  Millions
Theravance Biopharma inc   0.24 $ 109.775  Millions$ 449.845  Millions
Revvity Inc  0.24 $ 2,902.407  Millions$ 12,166.686  Millions
Cryoport inc   0.24 $ 182.935  Millions$ 769.213  Millions
Enanta Pharmaceuticals Inc  0.24 $ 69.213  Millions$ 294.299  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.